SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-296678
Filing Date
2013-07-22
Accepted
2013-07-22 09:45:33
Documents
4
Period of Report
2013-07-19
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d571327d8k.htm 8-K 20449
2 EX-3.1 d571327dex31.htm EX-3.1 7121
3 EX-99.1 d571327dex991.htm EX-99.1 6178
4 GRAPHIC g571327ex99_1pg001.jpg GRAPHIC 8143
  Complete submission text file 0001193125-13-296678.txt   46486
Mailing Address 1500 WEST PARK DRIVE SUITE 210 WESTBOROUGH MA 01581
Business Address 1500 WEST PARK DRIVE SUITE 210 WESTBOROUGH MA 01581 (508) 767-3861
RXi Pharmaceuticals Corp (Filer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54910 | Film No.: 13978448
SIC: 2834 Pharmaceutical Preparations